We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+13.23%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$138B
AUM Growth
+$12.8B
(+10%)
Cap. Flow
-$1.91B
Cap. Flow
% of AUM
-1.38%
Top 10 Holdings %
Top 10 Hldgs %
30.43%
Holding
301
New
8
Increased
70
Reduced
156
Closed
8
Avg Time Held
4.4
years
Top 10 Avg Time Held
4.6
years
Top 20 Avg Time Held
3.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$258M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$88.2M |
| 3 |
Visa
V
|
+$74.2M |
| 4 |
Raymond James Financial
RJF
|
+$72.1M |
| 5 |
LivaNova
LIVN
|
+$70.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$304M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$283M |
| 3 |
Insulet
PODD
|
+$255M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$242M |
| 5 |
Adobe
ADBE
|
+$229M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Healthcare | 26.48% |
| 3 | Industrials | 14.72% |
| 4 | Financials | 10.81% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
FSCT
201
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $26M | 0.02% |
791,750
+54,100
| +7% | +$1.77M |
2019 Q3
1 quarter
|
|
202
DELISTED
Spirit Airlines, Inc.
SAVE
| $24.7M | 0.02% |
612,765
| – | – |
2013 Q2
26 quarters
|
|
203
OSI Systems
OSIS
$3.13B
| $23.8M | 0.02% |
236,100
| – | – |
2016 Q1
15 quarters
|
|
204
nVent Electric
NVT
$23.6B
| $23.6M | 0.02% |
923,700
-400
| -0% | -$9.3K |
2018 Q2
6 quarters
|
|
|
SPPI
205
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $23.4M | 0.02% |
6,416,000
-4,559,800
| -42% | -$36.8M |
2017 Q3
9 quarters
|
|
|
PRSP
206
DELISTED
Perspecta Inc. Common Stock
PRSP
| $22.7M | 0.02% |
859,101
-8,145
| -0.9% | -$217K |
2018 Q2
6 quarters
|
|
207
Standard BioTools
LAB
$258M
| $22.5M | 0.02% |
6,477,843
-15,300
| -0.2% | -$53.8K |
2013 Q2
26 quarters
|
|
208
DELISTED
Amicus Therapeutics
FOLD
| $22.4M | 0.02% |
2,295,000
+97,500
| +4% | +$893K |
2019 Q3
1 quarter
|
|
|
MYOK
209
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $21.6M | 0.02% |
296,726
-5,474
| -2% | -$332K |
2019 Q2
2 quarters
|
|
210
Public Service Enterprise Group
PEG
$35B
| $21.6M | 0.02% |
365,279
| – | – |
2013 Q2
26 quarters
|
|
211
Cerence
CRNC
$415M
| $21.4M | 0.02% |
+947,017
| New | +$15.5M |
2019 Q4
0 quarters
|
|
212
Arlo Technologies
ARLO
$1.34B
| $20.8M | 0.02% |
4,937,340
-116,400
| -2% | -$400K |
2018 Q3
5 quarters
|
|
213
Enovis
ENOV
$1.12B
| $20.2M | 0.01% |
322,862
+1,220
| +0.4% | +$69K |
2019 Q3
1 quarter
|
|
214
OneSpaWorld
OSW
$2.43B
| $20.2M | 0.01% |
1,200,000
| – | – |
2019 Q1
3 quarters
|
|
|
LGF.A
215
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $19.8M | 0.01% |
1,860,186
| – | – |
2016 Q4
12 quarters
|
|
216
Autodesk
ADSK
$51.2B
| $19.6M | 0.01% |
107,000
+2,000
| +2% | +$324K |
2017 Q4
8 quarters
|
|
217
Baidu
BIDU
$28.1B
| $19.4M | 0.01% |
+153,605
| New | +$17.5M |
2019 Q4
0 quarters
|
|
218
Waters Corp
WAT
$43.6B
| $19.3M | 0.01% |
82,740
-198,917
| -71% | -$43.9M |
2013 Q2
26 quarters
|
|
219
DELISTED
Immunogen Inc
IMGN
| $18.8M | 0.01% |
3,674,927
-18,873
| -0.5% | -$64.1K |
2013 Q2
26 quarters
|
|
|
SREV
220
DELISTED
ServiceSource International, Inc.
SREV
| $18.3M | 0.01% |
10,984,733
-1,679,400
| -13% | -$2.19M |
2014 Q1
23 quarters
|
|
221
Boot Barn
BOOT
$3.65B
| $18M | 0.01% |
405,000
-164,014
| -29% | -$6.48M |
2015 Q1
19 quarters
|
|
222
Philip Morris
PM
$312B
| $17.7M | 0.01% |
208,000
-2,050
| -1% | -$169K |
2017 Q2
10 quarters
|
|
223
Glaukos
GKOS
$9.77B
| $17.3M | 0.01% |
318,200
+35,900
| +13% | +$2.18M |
2017 Q4
8 quarters
|
|
224
Materialise
MTLS
$467M
| $16.5M | 0.01% |
901,800
+15,400
| +2% | +$284K |
2018 Q2
6 quarters
|
|
225
nLIGHT
LASR
$2.05B
| $14.9M | 0.01% |
735,321
+69,921
| +11% | +$1.21M |
2018 Q2
6 quarters
|
|
Similar funds
Primecap Management's Q4 2019 Portfolio in Review
As of Q4 2019, Primecap Management held 301 positions worth $138B, up 10% from $125B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Primecap Management's Q4 2019 filing shows 8 new, 70 increased, 156 reduced and 8 closed positions. Its largest new stake was BioNTech: 2,128,182 shares worth $72.1M. The largest sale was Alphabet (Google) Class C, an estimated $304M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q4 2019 buy was BioNTech: 2,128,182 shares worth $72.1M.
- Primecap Management added most to Biogen in Q4 2019, an estimated $258M increase.
- Primecap Management's biggest Q4 2019 reduction was Alphabet (Google) Class C, cutting an estimated $304M.
- Primecap Management fully exited Spirit AeroSystems in Q4 2019, selling an estimated $13.5M.
- Primecap Management's ten largest holdings make up 30% of its $138B portfolio in Q4 2019.
- Primecap Management opened 8 new positions and closed 8 in Q4 2019.
- Primecap Management's portfolio value rose 10% quarter-over-quarter to $138B.
Based on Primecap Management's 13F filing for Q4 2019, filed 14 Feb 2020.